Nothing Special   »   [go: up one dir, main page]

ATE352785T1 - Verfahren zum nachweis von hepatitis c antigenen - Google Patents

Verfahren zum nachweis von hepatitis c antigenen

Info

Publication number
ATE352785T1
ATE352785T1 AT00952184T AT00952184T ATE352785T1 AT E352785 T1 ATE352785 T1 AT E352785T1 AT 00952184 T AT00952184 T AT 00952184T AT 00952184 T AT00952184 T AT 00952184T AT E352785 T1 ATE352785 T1 AT E352785T1
Authority
AT
Austria
Prior art keywords
hepatitis
antigens
detecting hepatitis
virus
detecting
Prior art date
Application number
AT00952184T
Other languages
English (en)
Inventor
David Y Chien
Phillip Arcangel
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE352785T1 publication Critical patent/ATE352785T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/18Togaviridae; Flaviviridae
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00952184T 1999-07-28 2000-07-25 Verfahren zum nachweis von hepatitis c antigenen ATE352785T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14607999P 1999-07-28 1999-07-28

Publications (1)

Publication Number Publication Date
ATE352785T1 true ATE352785T1 (de) 2007-02-15

Family

ID=22515775

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952184T ATE352785T1 (de) 1999-07-28 2000-07-25 Verfahren zum nachweis von hepatitis c antigenen

Country Status (10)

Country Link
EP (1) EP1295126B1 (de)
JP (2) JP5498637B2 (de)
AT (1) ATE352785T1 (de)
CA (1) CA2380777C (de)
CY (1) CY1106349T1 (de)
DE (1) DE60033190T2 (de)
DK (1) DK1295126T3 (de)
ES (1) ES2279766T3 (de)
PT (1) PT1295126E (de)
WO (1) WO2001009609A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702183D0 (en) * 2007-02-05 2007-03-14 Iti Scotland Ltd Pathogen binding
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN105209616A (zh) 2013-03-14 2015-12-30 雅培制药有限公司 用于改进的抗体检测的hcv ns3重组抗原及其突变体
US9194873B2 (en) 2013-03-14 2015-11-24 Abbott Laboratories HCV antigen-antibody combination assay and methods and compositions for use therein
EP3916103A1 (de) 2013-03-14 2021-12-01 Abbott Laboratories Monoklonale antikörper gegen hcv-core lipid-bindender domäne

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
FR2502154A1 (fr) * 1981-03-30 1982-09-24 Trepo Christian Procede de preparation d'antigenes de l'hepatite virale nanb, et application a la realisation d'un reactif permettant le diagnostic et le pronostic des infections provoquees par les virus des hepatites virales
US5308750A (en) * 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
EP0569537B1 (de) * 1991-01-31 1998-06-17 Abbott Laboratories Monoklonale antikörper gegen mögliche hcv-hüllregionen und methoden diese zu benutzen
WO1993006488A1 (en) * 1991-09-16 1993-04-01 Genelabs Technologies, Inc. Peptide based hepatitis c virus immunoassays
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
GB9214877D0 (en) * 1992-07-14 1992-08-26 Smith Meters Ltd Dry gas meter
JPH06327482A (ja) * 1993-05-21 1994-11-29 Imuno Japan:Kk オリゴペプタイド、オリゴヌクレオチドならびにc型肝炎ウ イルス関連抗体検出方法
US6747136B2 (en) * 1996-04-19 2004-06-08 Karolinska Innovations Ab Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
AU9497998A (en) * 1997-09-22 1999-04-12 Chiron Corporation Method for detecting antibodies in a sample

Also Published As

Publication number Publication date
EP1295126A2 (de) 2003-03-26
CA2380777A1 (en) 2001-02-08
WO2001009609A3 (en) 2003-01-09
ES2279766T3 (es) 2007-09-01
WO2001009609A2 (en) 2001-02-08
JP5498637B2 (ja) 2014-05-21
JP2010048830A (ja) 2010-03-04
DE60033190T2 (de) 2007-10-31
DK1295126T3 (da) 2007-04-10
CA2380777C (en) 2011-01-04
CY1106349T1 (el) 2011-10-12
PT1295126E (pt) 2007-03-30
EP1295126B1 (de) 2007-01-24
DE60033190D1 (de) 2007-03-15
JP2003529744A (ja) 2003-10-07

Similar Documents

Publication Publication Date Title
ATE376187T1 (de) Nachweis von erkrankungen der nieren und behandlung
DE60013287D1 (de) Früherkennung der flaviviren unter verwendung des ns1-glycoproteins
ATE446745T1 (de) Antikörper mit t-zell-rezeptor-artiger spezifität,aber höherer affinität und seine verwendung zum nachweis und zur behandlung von krebs, virusinfektionen und autoimmunkrankheiten
FI20021626A (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
EP0914155A4 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
ATE118275T1 (de) Immunoassayverfahren zum nachweis von antigenen.
DE60110256D1 (de) Verfahren zum konzentrieren von analyten in proben
DE59007613D1 (de) Verfahren zum Nachweis und zur Bestimmung von Humanserumalbumin in biologischen Flüssigkeiten mit Hilfe fluorogener Cyanin-Farbstoffe.
DE68923605D1 (de) Immunodiagnostisches Verfahren zum Nachweis und zur Bestimmung von Euterentzündung.
EP0248534A3 (de) Verfahren zum Nachweis einer AIDS-Virus-Infektion
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
ATE352785T1 (de) Verfahren zum nachweis von hepatitis c antigenen
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE105086T1 (de) Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b.
ATE112392T1 (de) Agglutinationskomplex zum nachweis von blutgruppen.
ATE539350T1 (de) Verfahren zum nachweis oder zum bestimmen von hbv
ATE132268T1 (de) Immuntest zum gleichzeitigen nachweis von hiv-1, hiv-2, htlv-i und htlv-ii antikörpern
ATE367582T1 (de) Verfahren zum nachweis von borna-disease-virus (bdv)- infektionen
CA2095735A1 (en) Monoclonal antibodies to hepatitis c virus and method for using same
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens
GR3029320T3 (en) Monoclonal antibodies to putative hcv ns5 proteins and methos for using same.
DE3853315D1 (de) Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens.
DE3783840D1 (de) Verfahren zur bestimmung von plasma-protein und testsatz dafuer.
DE58902996D1 (de) Verfahren zum nachweis von antikoerpern gegen erythrozytenspezifische antigene.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1295126

Country of ref document: EP